Direct access Research units

After more than eight years of join research with the team of Alain Wagner, we are happy to announce the creation of MicroOmix, the first start-up cofounded by Michael RYCKELYNCK. By converting microfluidic droplets into ultrasensitive sensors, the company provides a sensitive and resolutive high-throughput single-cell secretome analysis and sorting technology. We expect it to have a major impact in the field of therapeutic antibody, regenerative medicine and stem cell biology. The development of this technology benefited from the financial support of the LabEx NetRNA among other financers.

Share This